Skip to content
Vivo logo
← All articles

NAD+ Cream Benefits: What the Evidence Supports

NAD+ Cream Benefits: What the Evidence Supports

Geometric illustration of evidence and uncertainty

NAD+ creams may support skin barrier function, hydration, tone and the look of fine lines, but the strongest clinical evidence belongs to a related ingredient, nicotinamide (niacinamide), a precursor the skin converts into NAD+. Direct NAD+ applied to the skin is a large molecule with limited penetration, so the formulation matters as much as the name on the label. This article reviews what the research shows, where claims outrun the data, and how to evaluate a product, including a prescription option.

Vivo Clinicvivoclinic.orgExplore a Provider-Reviewed NAD+ CreamVivo Clinic offers a provider-reviewed NAD+ Face Cream after a telehealth evaluation, with treatment selection guided by a provider.Explore NAD+ face cream

TL;DR

  • Best-supported benefit: topical nicotinamide, a NAD+ precursor, has randomized-trial data for fine lines, texture, hyperpigmentation and elasticity at about 5% concentration over 12 weeks.
  • Main caveat: NAD+ itself penetrates the epidermis poorly, so effective “NAD creams” generally rely on precursors that skin cells convert to NAD+.
  • Not a miracle ingredient: dermatologists describe it as a complement to retinoids, vitamin C and daily broad-spectrum sunscreen, not a replacement.
  • Regulation: most non-prescription NAD+ skincare is not FDA-approved, so third-party verification and transparent labeling matter.
  • Prescription route: Vivo Clinic offers a provider-reviewed NAD+ Face Cream at 129 USD per month, available only after a telehealth evaluation.

Table of Contents

What NAD+ does in skin

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell. According to dermatologists interviewed by NBC Select, it is involved in cellular energy metabolism, DNA repair, oxidative stress regulation and mitochondrial activity, and in skin it helps maintain epidermal structure, supports DNA repair after UV exposure and influences inflammatory pathways.

Research summarized by Byrdie’s dermatologist panel suggests that NAD+ levels decline with age and that UV radiation contributes to that decline in skin. That decline is the rationale behind topical products: if skin cells have less NAD+ available, supplying the raw material could, in theory, support repair processes.

“In theory” is the operative phrase. The biology of NAD+ is well established. The evidence that a cream raises NAD+ levels in living human skin, and that this produces visible results, is much thinner than the marketing suggests.

Direct NAD+ versus precursors: the distinction that matters

Many consumers assume that applying pure NAD+ delivers the same cellular benefit as the molecule inside the body. Dermatologists quoted by NBC Select say NAD+ is not particularly effective when applied directly, because of its relatively large molecular size and limited ability to cross the epidermis. Topical formulations tend to perform better when they include precursors, such as niacinamide or NMN, that skin cells can convert to NAD+ internally.

A review in PMC on nicotinamide and skin aging makes a related point: the effect of topical nicotinamide is often indirect, since it acts as a precursor to NAD+ and other metabolites. It is well tolerated at 4 to 5% concentrations, and precursor-based formulations currently carry more robust clinical support for skin homeostasis and DNA repair cofactor activity than direct NAD+ products.

This is why a label reading “NAD+” tells you little by itself. A useful product description states what form of NAD+ or precursor is present, at what concentration, and in what delivery system. For a deeper look at how skincare brands handle this, an explainer on niacinamide and peptides shows how a timeline-based trial can be used to document results from precursor ingredients.

Direct NAD+ versus precursors: the distinction that matters — overview diagram

Potential benefits of NAD+ and precursor creams

The benefits below are listed in order of strength of evidence, with the source of each claim.

Fine lines, texture and uneven tone

The best clinical data concern nicotinamide. According to the PMC review, a 2011 randomized trial found that 5% nicotinamide applied for 12 weeks improved fine lines, wrinkles, texture, hyperpigmentation and elasticity. This is evidence for a precursor, not for a specific NAD+ cream, and it should not be transferred automatically to any product that uses the NAD+ name.

Barrier function and hydration

Barrier support is the benefit dermatologists cite most consistently for topical NAD+ products. One dermatologist in the NBC Select report describes topical NAD+ support as helping skin function better at the surface, including strengthening the barrier. Manufacturers also publish their own trial figures, but these are company-sponsored, small and specific to a proprietary formula, so they should be read as product claims rather than class-wide findings.

Inflammatory skin conditions

The top search results for this topic often raise eczema and psoriasis. The evidence here is limited and again concerns nicotinamide. In a pilot, double-blind, randomized study, a combination of calcipotriene and nicotinamide was tested against calcipotriene alone for psoriasis. The PMC review reports that 50% of patients on the combination reached a “clear to almost clear” outcome at 12 weeks, compared with 31.5% on calcipotriene alone, using 1.4% nicotinamide. That was a small pilot study of a drug-plus-nicotinamide combination. It does not show that a NAD+ cream treats psoriasis or eczema, and anyone with a diagnosed skin condition should discuss it with a dermatologist before changing treatment.

Pilot study outcomes at twelve weeks compared

Complement to an established routine

Dermatologists consulted by Byrdie emphasize that NAD+ should not be viewed as a miracle cure. It is best treated as one ingredient in a regimen that includes proven anti-aging components such as retinoids, vitamin C and broad-spectrum sunscreen. Sunscreen in particular addresses the UV exposure that is thought to deplete skin NAD+ in the first place.

What the evidence does not show

Honest evaluation requires listing the gaps:

  • No head-to-head proof for direct NAD+ creams. The robust trials use nicotinamide, not NAD+ itself.
  • Short durations. The cited trials run about 12 weeks. Long-term outcomes of NAD+ creams are not established in the sources reviewed here.
  • Brand-funded data. Percentages such as reductions in water loss or gains in radiance come from manufacturer testing of proprietary formulas.
  • Topical is not systemic. A cream acts locally. It is not a substitute for oral, nasal or injectable NAD+ and is not expected to change whole-body NAD+ levels.
  • Individual response varies. Skin type, baseline condition, sun exposure and routine all affect results.

For readers interested in the systemic side, Vivo Clinic has reviewed the research on NAD+ for energy, which found no consistent functional gains across the studies examined.

How to evaluate an NAD+ cream

Because quality varies widely, a short checklist helps.

  1. Identify the active. Is it NAD+ itself, nicotinamide/niacinamide, NMN or another precursor? Concentration should be stated.
  2. Check for regulatory status. The American Academy of Dermatology notes that supplements and similar products are not regulated by the FDA in the way prescription drugs are, meaning manufacturers need not prove safety or efficacy before sale. Look for third-party testing such as USP, NSF or ConsumerLab to confirm that what is on the label is in the jar.
  3. Look at storage and packaging. NAD-based formulations can be sensitive to heat, light and air. Some pharma-grade products recommend refrigeration, and one manufacturer’s guidance suggests potency may decline within roughly two months of opening if storage directions are not followed. Follow the instructions on the specific product.
  4. Ask who formulated it. A named formulator and a known source of ingredients are better signals than marketing language.
  5. Patch test. Apply a small amount to the inner forearm or behind the ear for several days before using on the face.
  6. Pair with sun protection. Apply broad-spectrum sunscreen each morning.

Over-the-counter creams versus a prescription option

Retail NAD+ creams are cosmetics. They can be sold without a medical evaluation, and their claims are limited to appearance. A prescription product is different in process: a licensed provider reviews health history, medications and goals before approving treatment, and the product is prepared by a pharmacy.

The FDA has reminded compounders to use only ingredients suitable for sterile compounding, after learning that some compounders were using food-grade NAD+ sold by repackagers. That warning concerns sterile products, chiefly injectables, but it illustrates the central point for any compounded therapy: pharmacy quality and ingredient sourcing matter. Patients should favor providers that work with licensed pharmacies operating under 503A or 503B standards.

Dimension Retail NAD+ cream Prescription NAD+ cream (telehealth)
Medical review before use None Provider evaluation and approval
Regulatory category Cosmetic Compounded prescription
Preparation Commercial manufacturer Licensed U.S. pharmacy
Ongoing oversight None Provider follow-up with refills
Evidence base Mostly manufacturer data Same limits for topical NAD+; provider judgment applies
Access Store or online Delivered to the home

A prescription does not turn a topical product into a proven treatment. What it adds is clinical screening, a defined formulation and continued supervision.

Our perspective

We see two common mistakes among people researching NAD+ creams. The first is assuming that any cream with “NAD+” on the label has been shown to work; the published evidence is stronger for precursors such as nicotinamide than for direct NAD+. The second is assuming that a topical product and a systemic therapy do the same job. They do not, and we prefer to say so plainly.

Our approach at Vivo Clinic is to match treatment to the individual. Patients complete a HIPAA-compliant telehealth intake, a licensed provider reviews the information, and any approved therapy is compounded by a licensed U.S. pharmacy and shipped to the patient. The same process applies whether the product is a cream, a nasal spray or an injection. We think health privacy, a named prescriber and a traceable pharmacy are reasonable things for any patient to ask about before starting.

We also encourage realistic expectations. A face cream is an addition to sun protection and a consistent routine, not a replacement for them. Anyone with a diagnosed skin condition, a history of reactions to topical products, or who is pregnant or nursing should raise it with a provider before use.

— Jack

Vivo Clinic’s prescription NAD+ face cream

For adults who want a provider-supervised option, Vivo Clinic offers the NAD+ Face Cream for 129 USD per month. Treatment begins with an online intake, and the cream is prescribed only if a licensed provider approves it. It is prepared by a licensed U.S. pharmacy and delivered to the patient’s door, with ongoing provider oversight for refills.

Patients who want to understand other routes of administration can compare the NAD+ Nasal Spray or the NAD+ Injection, and read about NAD+ nasal spray dosing. The provider can advise which, if any, fits an individual’s goals.

Questions to bring to a provider

  • What is the active ingredient, and at what concentration?
  • Which licensed pharmacy prepares the product, and is it a 503A or 503B facility?
  • How should the product be stored, and how long does it remain usable after opening?
  • How does it interact with retinoids, acids or prescription topicals I already use?
  • What results is it reasonable to expect, and over what period?
  • How is my health information stored and who can access it?

FAQ

Do NAD+ creams actually work?

There is evidence that topical nicotinamide, a NAD+ precursor, improves fine lines, texture and pigmentation in trials of about 12 weeks at roughly 5% concentration. Evidence specific to creams containing NAD+ itself is limited, and much of it comes from manufacturers. Results are modest and best viewed as part of a full routine.

Is NAD+ cream better than niacinamide?

Not on current evidence. Dermatologists note that NAD+ penetrates skin poorly, and precursor-based formulations have more clinical support. A product containing a well-formulated precursor may perform as well as or better than one containing NAD+ alone.

Can NAD+ cream help with psoriasis or eczema?

No cream has been shown to treat these conditions on the basis of NAD+ alone. A small pilot study found that nicotinamide combined with calcipotriene outperformed calcipotriene alone in psoriasis, but that is a drug combination in a limited trial. A dermatologist should guide treatment of any diagnosed condition.

Are NAD+ skin creams FDA-approved?

Most non-prescription NAD+ products are not FDA-approved, so manufacturers are not required to demonstrate safety or efficacy before sale, according to the American Academy of Dermatology. Compounded prescription products are also not FDA-approved, which is why the licensing of the prescriber and the pharmacy matters.

When is the best time to apply NAD+ cream?

Many products are designed for nighttime use, but follow the directions for the specific product. Use broad-spectrum sunscreen during the day regardless of what you apply at night.

Sources